| http://www.w3.org/ns/prov#value | - ???Dendreon CEO Mitchell Gold didn???t dive into the statistical nitty-gritty of the Provenge clinical trial results this week, but he told investors this week the findings were ???unambiguous??? and a ???clear hit??? that showed the drug can help men live longer with terminal forms of prostate cancer.
|
